Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
August 9, 2011
MIAMIFor several years, soy has been considered the magic bullet for menopause. Not anymore. A new study conducted at the Miller Schools Osteoporosis Center at the University of Miami showed that, contrary to popular belief, soy isoflavone supplements neither prevent bone loss nor reduce menopausal symptoms.
The consumption of soy foods and soy supplements has dramatically increased in the last few years, particularly among women who start taking various over-the-counter products around the time of menopause, believing that these products will provide all the benefits and none of the risks of menopausal hormone therapy," said Silvina Levis, M.D., professor of medicine, director of the Osteoporosis Center, principal investigator and lead author of the study. Our study showed that soy phytoestrogen tablets do not provide any benefit, but fortunately do not cause any apparent harm either. The participants had the same rates of bone loss and menopausal symptoms, whether they were taking soy tablets or placebo tablets (sugar pills). The women on the soy tablets actually had more constipation and abdominal bloating."
The participants, women aged 45 to 60 and within five years of menopause, were randomly assigned, in equal proportions, to receive either daily soy isoflavone tablets or the placebo and were not aware of which they were taking.
The women were followed for two years and underwent a bone density test (DXA) at the beginning and the end of the study to measure the rate of bone loss. The study showed no meaningful difference in the rate of bone loss between those taking the soy tablets and those taking the placebo. Additionally, those women taking the soy supplement reported no measurable improvement in the number or severity of menopausal symptoms such as hot flashes, or in vaginal cytology or cholesterol levels.
According to a UM press release, the study is not an endorsement of hormone therapy, but it did objectively demonstrate that women who take soy isoflavone supplements will not see any clinical benefits.
The findings of the SPARE Study, which stands for Soy Phytoestrogens As Replacement Estrogen, were published in the August 8 issue of the Archives of Internal Medicine.
You May Also Like
Formulating the future: The industry may not be ready for AI in product development, and AI might not be ready for the industry, eitherFeb 20, 2024
Beyond the primary outcome: How exploratory analysis can deliver unexpected new insightsFeb 19, 2024
Survey shows dietitians concerned about TikTok misinformationFeb 16, 2024
Akay Bioactives' ThymoDream™: Improves non-restorative sleep in just 7 days – press releaseFeb 16, 2024